Nuveen Dow 30 Dynamic Overwrite Fund (DIAX): Potential Merger and Shrinkage in NAV Discount

Nuveen Dow 30 Dynamic Overwrite Fund (DIAX) is a buy-write CEF with a poor track record. The fund's discount to NAV could shrink as merger talks are underway. DIAX has generated positive returns over the past year, but its long-term performance is concerning. Investors should be cautious when considering this fund, especially given its history of poor performance.